Renato D. Lopes
Renato D. Lopes
Professor afiliado da EPM/UNIFESP
E-mail confirmado em
Citado por
Citado por
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
Apixaban versus warfarin in patients with atrial fibrillation
CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ...
New England Journal of Medicine 365 (11), 981-992, 2011
2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed …
Authors/Task Force Members, AJ Camm, GYH Lip, R De Caterina, ...
European heart journal 33 (21), 2719-2747, 2012
Initial invasive or conservative strategy for stable coronary disease
DJ Maron, JS Hochman, HR Reynolds, S Bangalore, SM O’Brien, ...
New England Journal of Medicine 382 (15), 1395-1407, 2020
Sotagliflozin in patients with diabetes and recent worsening heart failure
DL Bhatt, M Szarek, PG Steg, CP Cannon, LA Leiter, DK McGuire, ...
New England journal of medicine 384 (2), 117-128, 2021
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
Apixaban with antiplatelet therapy after acute coronary syndrome
JH Alexander, RD Lopes, S James, R Kilaru, Y He, P Mohan, DL Bhatt, ...
New England Journal of Medicine, 2011
Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial
BM Tomazini, IS Maia, AB Cavalcanti, O Berwanger, RG Rosa, VC Veiga, ...
Jama 324 (13), 1307-1316, 2020
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
AB Cavalcanti, FG Zampieri, RG Rosa, LCP Azevedo, VC Veiga, ...
New England Journal of Medicine 383 (21), 2041-2052, 2020
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation
RD Lopes, G Heizer, R Aronson, AN Vora, T Massaro, R Mehran, ...
New England Journal of Medicine 380 (16), 1509-1524, 2019
Sotagliflozin in patients with diabetes and chronic kidney disease
DL Bhatt, M Szarek, B Pitt, CP Cannon, LA Leiter, DK McGuire, JB Lewis, ...
New England Journal of Medicine 384 (2), 129-139, 2021
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ...
New England Journal of Medicine 366 (1), 20-33, 2012
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
SH Hohnloser, Z Hijazi, L Thomas, JH Alexander, J Amerena, M Hanna, ...
European heart journal 33 (22), 2821-2830, 2012
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
N Sattar, MMY Lee, SL Kristensen, KRH Branch, S Del Prato, NS Khurmi, ...
The lancet Diabetes & endocrinology 9 (10), 653-662, 2021
Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021
ME Oster, DK Shay, JR Su, J Gee, CB Creech, KR Broder, K Edwards, ...
Jama 327 (4), 331-340, 2022
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale
RD Lopes, JH Alexander, SM Al-Khatib, J Ansell, R Diaz, JD Easton, ...
American heart journal 159 (3), 331-339, 2010
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Z Hijazi, J Oldgren, J Lindbäck, JH Alexander, SJ Connolly, ...
The Lancet 387 (10035), 2302-2311, 2016
Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II registry
BA Steinberg, P Shrader, L Thomas, J Ansell, GC Fonarow, BJ Gersh, ...
Journal of the American College of Cardiology 68 (24), 2597-2604, 2016
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ...
Jama 326 (6), 499-518, 2021
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20